NATIONWIDE — Detect, Inc. is voluntarily recalling specific lots of the Detect Covid-19 Test™, a molecular, over-the-counter test used to identify SARS-CoV-2 (the virus that causes COVID-19) in self-collected nasal swabs. 

The recall affects a total of 11,102 tests shipped to customers from July 26, 2022 through August 26, 2022. 

The test was granted Emergency Use Authorization (EUA) from the U.S. Food and Drug Administration (FDA) on October 28, 2021. There is an increased chance that the tests from the lot numbers listed below could give false-negative results. Detect has investigated this issue and has decided to recall the lots. 

To date, Detect has not received any reports of false-negative results related to the affected lots, and is issuing this recall out of an abundance of caution.  The reliability of positive test results is not affected.